RxDoctor Payments Data
★ My doctorsLook up a doctor →

Thomas Davenport, MD

Plastic and Reconstructive Surgery · Garden City, NYNPI 1174583405

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $2,815,500 of the $2,832,209 with a category attached, or 99.4%. Xtant Medical Inc accounts for 99.4% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $2,817,573, more than ten times the $1,857 reported in 2019. Among plastic and reconstructive surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,832,209in general payments, 2019–2025

Across 176 payments — averaging $16,092 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Xtant Medical Inc$2.8M
  • TELA Bio, Inc.$4K
  • AbbVie$4K
  • Davol Inc.$2K
  • Sientra, Inc.$1K
  • Axogen$1K
  • plus $5K from 23 others

What the payments were for

  • Royalty or licence$2,815,50099%
  • Consulting fees$1,5250%
  • Speaking & faculty fees$1,0540%
  • Grants$2,0950%
  • Travel & lodging$2,3470%
  • Food & beverage$8,9180%
  • Education$7690%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Xtant Medical Inc3$2,815,500
TELA Bio, Inc.31$4,386
AbbVie(2 entities)47$3,756
Davol Inc.7$1,569
Sientra, Inc.11$1,156
Axogen11$1,146
Stryker2$750
Smith+Nephew19$720
Avita Medical Americas, LLC6$556
Motiva USA, LLC2$364
Polarityte, Inc.4$341
Mentor Worldwide LLC7$327
BD1$275
Lifenet Health4$221
Tepha Inc2$195
Medline Industries LP2$173
Deroyal Industries, Inc.2$161
Sanara Medtech Inc.1$144
Musculoskeletal Transplant Foundation Inc.1$97
Convatec Inc.3$73
Acera Surgical, Inc.1$63
Polynovo North America LLC1$43
Mimedx Group, Inc.1$42
Integra Lifesciences Corporation2$36
Bioventus LLC1$33
KCI USA, Inc.1$26
OVIK Health, LLC1$21
Baxter Healthcare1$18
Cumberland Pharmaceuticals, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,832,209 in reported general payments places this provider in the 95th percentile of 219 plastic and reconstructive surgery providers in New York.

See all plastic and reconstructive surgery providers in New York →

Medicare billing

Part B allowed, 2024
$531,602
Medicare patients
333
Services billed
1,129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Garden City

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →